Retraction
Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway
Paper Information
Record ID:
64496
Publication Date:
May 08, 2014
Retraction Date:
February 20, 2025
(<1 year years ago)
Subjects:
Institutions:
- Department of Surgery, Tongji Hospital, Tongji University School of Medicine, Tongji University, Shanghai, P.R. China
- Department of Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Tongji University, Shanghai, P.R. China
- Department of Surgery, Shanghai Pudong New Area People's Hospital, Shanghai, P.R. China
- Department of Oncology, Shanghai Yangpu Geriatric Hospital, Shanghai, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Author Unresponsive
- Concerns/Issues About Data
- Concerns/Issues About Image
- Concerns/Issues about Article
- Concerns/Issues about Results and/or Conclusions
- Duplication of Data
- Duplication of/in Image
- Euphemisms for Duplication
- Euphemisms for Plagiarism
- Investigation by Journal/Publisher
- Original Data and/or Images not Provided and/or not Available
- Plagiarism of Data
- Plagiarism of Image
- Unreliable Data
- Unreliable Image
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0319593Citations (35)
35
Total Citations2
Post-Retraction(5.7%)
32
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
45
Days since retraction (latest)
Nanotherapeutic strategies exploiting biological traits of cancer stem cells
Hongyu Wang, Wenjing Zhang, Yun Sun et al. (8 authors)
Bioactive Materials
Published: Apr 2025
45 days after retraction
Current knowledge on the mechanisms underpinning vasculogenic mimicry in triple negative breast cancer and the emerging role of nitric oxide
Belete Kassa Alemu, Sara Tommasi, Julie-Ann Hulin et al. (5 authors)
Biomedicine & Pharmacotherapy
Published: Mar 2025
36 days after retraction
Retraction: Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by Norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway
Unknown Authors
PLoS ONE
Open Access
Published: Feb 2025
Same day as retraction
Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification
Peng Huang, Xi Zhang, Jyothi S. Prabhu et al. (4 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Apr 2024
4 citations
4 citations
314 days before retraction
The Role of Paxillin Aberrant Expression in Cancer and Its Potential as a Target for Cancer Therapy
W. Liu, X J Huang, Weizhao Luo et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: May 2023
10 citations
10 citations
658 days before retraction
In vitro Characterization of a novel murine model of cancerous progression
Steven D. Scahill, Kelly Jean Sherman, Jessie J. Guidry et al. (9 authors)
Advances in Cancer Biology - Metastasis
Open Access
Published: May 2023
1 citation
1 citation
659 days before retraction
Review targeted drug delivery systems for norcantharidin in cancer therapy
Bingtao Zhai, Jing Sun, Yajun Shi et al. (9 authors)
Journal of Nanobiotechnology
Open Access
Published: Dec 2022
45 citations
45 citations
810 days before retraction
Arthropods in Cosmetics, Pharmaceuticals and Medicine: A Review
C.I. Ebenebe, Simon Okweche, O. O. Okore et al. (8 authors)
IntechOpen eBooks
Open Access
Published: Nov 2021
4 citations
4 citations
1184 days before retraction
Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro
Xinglu Chen, Xiangsheng Cai, Dianpeng Zheng et al. (10 authors)
Anti-Cancer Drugs
Published: Jul 2021
4 citations
4 citations
1319 days before retraction
Vasculogenic mimicry, a complex and devious process favoring tumorigenesis – Interest in making it a therapeutic target
Lucas Treps, Sébastien Faure, Nicolas Clere
Pharmacology & Therapeutics
Open Access
Published: Jan 2021
70 citations
70 citations
1494 days before retraction
Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway
Mu‐Su Pan, Hui Wang, Kamar Hasan Ansari et al. (6 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Nov 2020
55 citations
55 citations
1568 days before retraction
Predicting the combined toxicity of binary metal mixtures (Cu–Ni and Zn–Ni) to wheat
Xuedong Wang, Xiaorong Luo, Wang Qixin et al. (5 authors)
Ecotoxicology and Environmental Safety
Open Access
Published: Sep 2020
9 citations
9 citations
1615 days before retraction
Advances in freshwater risk assessment: improved accuracy of dissolved organic matter-metal speciation prediction and rapid biological validation
Xiaokai Zhang, Boling Li, Jianming Deng et al. (6 authors)
Ecotoxicology and Environmental Safety
Published: Jun 2020
11 citations
11 citations
1706 days before retraction
Insight into norcantharidin, a small-molecule synthetic compound with potential multi-target anticancer activities
Mu‐Su Pan, Jin Cao, Yue‐Zu Fan
Chinese Medicine
Open Access
Published: May 2020
41 citations
41 citations
1728 days before retraction
Role of EphA2‑PI3K signaling in vasculogenic mimicry induced by cancer‑associated fibroblasts in gastric cancer cells
Hee Jung Kim, You Jin Won, Ju Hyun Shim et al. (6 authors)
Oncology Letters
Open Access
Published: Jul 2019
30 citations
30 citations
2036 days before retraction
The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models
Giovanni Luca Gravina, A. Mancini, Alessandro Colapietro et al. (16 authors)
Cancers
Open Access
Published: Mar 2019
46 citations
46 citations
2171 days before retraction
Cancer‑associated fibroblast regulation of tumor neo‑angiogenesis as a therapeutic target in cancer (Review)
Fang‐Tao Wang, Wei Sun, Jingtao Zhang et al. (4 authors)
Oncology Letters
Open Access
Published: Jan 2019
100 citations
100 citations
2218 days before retraction
Integrin β1 is an essential factor in vasculogenic mimicry of human cancer cells
Ryota Kawahara, Yuki Niwa, Siro Simizu
Cancer Science
Open Access
Published: Jun 2018
52 citations
52 citations
2443 days before retraction
Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
Jiwei Guo, Yan Wu, Jing Du et al. (10 authors)
Oncogenesis
Open Access
Published: Jun 2018
96 citations
96 citations
2444 days before retraction
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Federica Lo Sardo, Sabrina Strano, Giovanni Blandino
Cancers
Open Access
Published: May 2018
110 citations
110 citations
2482 days before retraction
Whole-cell bioreporters and risk assessment of environmental pollution: A proof-of-concept study using lead
Xiaokai Zhang, Boqiang Qin, Jianming Deng et al. (4 authors)
Environmental Pollution
Published: Aug 2017
28 citations
28 citations
2759 days before retraction
Extended biotic ligand model for predicting combined Cu–Zn toxicity to wheat ( Triticum aestivum L.): Incorporating the effects of concentration ratio, major cations and pH
Xuedong Wang, Dongxue Ji, Xiaolin Chen et al. (7 authors)
Environmental Pollution
Published: Jul 2017
25 citations
25 citations
2787 days before retraction
Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers <i>via</i> activating the TGF-β1-SMAD3-ID1 signaling pathway
Zhongyan Liu, Jin Cao, Jingtao Zhang et al. (9 authors)
Oncotarget
Open Access
Published: May 2017
13 citations
13 citations
2828 days before retraction
Anti-angiogenic treatment promotes triple-negative breast cancer invasion via vasculogenic mimicry
Huizhi Sun, Danfang Zhang, Zhi Yao et al. (13 authors)
Cancer Biology & Therapy
Open Access
Published: Feb 2017
90 citations
90 citations
2921 days before retraction
Microorganisms: Role for Crop Production and Its Interface with Soil Agroecosystem
Dhiman Mukherjee
Springer eBooks
Published: Jan 2017
5 citations
5 citations
2972 days before retraction
Repression of YAP by NCTD disrupts NSCLC progression
Jiwei Guo, Yan Wu, Lijuan Yang et al. (9 authors)
Oncotarget
Open Access
Published: Nov 2016
46 citations
46 citations
3008 days before retraction
Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways
LI-CHENG ZHENG, Mei-Due Yang, Chao-Lin Kuo et al. (10 authors)
Anticancer Research
Open Access
Published: Oct 2016
25 citations
25 citations
3037 days before retraction
The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment
Shuixian Li, Wen Meng, Ziwei Guan et al. (5 authors)
Biomedicine & Pharmacotherapy
Published: Mar 2016
85 citations
85 citations
3258 days before retraction
Association between Tumor Vasculogenic Mimicry and the Poor Prognosis of Gastric Cancer in China: An Updated Systematic Review and Meta-Analysis
Qiujun Guo, Yuan Yuan, Zhichao Jin et al. (9 authors)
BioMed Research International
Open Access
Published: Jan 2016
39 citations
39 citations
3338 days before retraction
Exploring the global animal biodiversity in the search for new drugs - insects
Dennis R.A. Mans, Shellice Sairras, Deeksha Ganga et al. (4 authors)
Journal of Translational Science
Open Access
Published: Jan 2016
9 citations
9 citations
3338 days before retraction
Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy
Yayuan Liu, Ling Mei, Chaoqun Xu et al. (11 authors)
Theranostics
Open Access
Published: Dec 2015
102 citations
102 citations
3360 days before retraction
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo
Xinping Li, Jing Wei, Jian-jun Sun et al. (8 authors)
BMC Cancer
Open Access
Published: Jul 2015
22 citations
22 citations
3506 days before retraction
Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma
Yayuan Liu, Ling Mei, Qianwen Yu et al. (11 authors)
ACS Applied Materials & Interfaces
Published: Jul 2015
74 citations
74 citations
3508 days before retraction
Norcantharidin enhances TIMP-2 anti-vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP-2 and MT1-MMP
Wei Zhu, Wei Sun, Jingtao Zhang et al. (6 authors)
International Journal of Oncology
Open Access
Published: Nov 2014
18 citations
18 citations
3751 days before retraction
Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells
Che‐Hsin Lee, Yuting Wu, Hung-Chun Hsieh et al. (6 authors)
Biochimie
Published: Jun 2014
36 citations
36 citations
3901 days before retraction
Quick Stats
Total Citations:
35
Years Since Retraction:
<1 year
Open Access:
Yes
Last Checked:
Jul 23, 2025